Deciphera Pharmaceuticals, Inc. Accounts Payable
Deciphera Pharmaceuticals, Inc. had Accounts Payable of $19.46 million as of 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2024-05-10
- 2024-03-31: Accounts Payable, Current $19.46M.
- 2023-12-31: Accounts Payable, Current $26.48M.
- 2023-09-30: Accounts Payable, Current $21.45M.
- 2023-06-30: Accounts Payable, Current $18.21M.
| Period end | Accounts Payable, Current |
|---|---|
| 2024-03-31 | $19.46M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $26.48M 10-Q · filed 2024-05-10 |
| 2023-09-30 | $21.45M 10-Q · filed 2023-10-30 |
| 2023-06-30 | $18.21M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $19.67M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $18.61M 10-K · filed 2024-02-07 |
| 2022-09-30 | $12.80M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $16.23M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $17.80M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $13.13M 10-K · filed 2023-02-07 |
| 2021-09-30 | $13.50M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $14.02M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $11.90M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $12.31M 10-K · filed 2022-02-08 |
| 2020-09-30 | $10.24M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $12.58M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $11.34M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $19.57M 10-K · filed 2021-02-09 |
| 2019-09-30 | $14.77M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $13.90M 10-Q · filed 2019-08-02 |
| 2019-03-31 | $10.94M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $8.31M 10-K · filed 2020-03-09 |
| 2018-09-30 | $6.05M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $6.94M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $5.56M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $4.39M 10-K · filed 2019-03-14 |
| 2016-12-31 | $1.41M 10-K · filed 2018-03-28 |